Quinoline derivatives as PDE10A enzyme inhibitors
US-2015376186-A1 · Dec 31, 2015 · US
Water soluble 4-azapodophyllotoxin analogs
US9783547B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9783547-B2 |
| Application number | US-201515111711-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 15, 2015 |
| Priority date | Jan 15, 2014 |
| Publication date | Oct 10, 2017 |
| Grant date | Oct 10, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to 4-azapodophyllotoxin analogs of formula (I) in which X, R 1 , R 2 , R 3 , R 4 and Ar are as defined in claim 1 , preferably a pharmaceutically acceptable salt thereof, optionally in the form of a solvate, a composition comprising said analogs, their use as medicament, in particular for the treatment of cancer, and a process for their preparation.
First claim
Opening claim text (preview).
The invention claimed is: 1. Compound of formula (I): in which X represents —CH 2 — or —CH 2 CH 2 —; R 1 and R 4 are independently selected from the group consisting of H, halogen, C 1 -C 4 -alkyl; R 2 and R 3 are independently selected from the group consisting of H, OH, C 1 -C 4 alkyl, C 1 -C 4 -alkoxy, C1-C4-alkylthio, halogen, trifluoromet…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- C07D491/056Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9783547B2 cover?
- The present invention relates to 4-azapodophyllotoxin analogs of formula (I) in which X, R 1 , R 2 , R 3 , R 4 and Ar are as defined in claim 1 , preferably a pharmaceutically acceptable salt thereof, optionally in the form of a solvate, a composition comprising said analogs, their use as medicament, in particular for the treatment of cancer, and a process for their preparation.
- Who is the assignee on this patent?
- Centre Nat De La Rech Scient (Cnrs), Univ Paris Descartes, Inst Nat De La Sante Et De La Rech Medicale (Inserm), and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C07D491/056. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).